Trial
NCT02177838
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Rutgers, The State University of New Jersey
Collaborators
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey
Condition
Stage III Squamous Cell Carcinoma of the Hypopharynx
Intervention
cetuximab
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-21